India's drug regulator plans reforms to ease export clearances and simplify manufacturing licenses to reduce workforce strain. With only 2,...

Indian-origin men, including a father-son duo, have been sentenced to a total of 24 years imprisonment after being convicted of running wha...

Ditch those health supplements as they have no health benefits, and are simply a money-making scheme by drug companies, according to a top ...

SII, the world's largest vaccine manufacturer, is producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor a...

Banks and construction companies were at the forefront of the rally this week.

India spooked the world this week by announcing curbs on exports of common drugs including paracetamol.

The tiny robots developed by researchers at the University of Manchester in the UK can be programmed to move and build molecular cargo usin...

The next wave of drug launches from an active pipeline of 25 clinical programmes will determine how strongly GSK charts its future growth.

Nestle India fell over 5% in intraday trade on Thursday, after FSSAI said that it has not given clean chit to Maggi noodles.

FSSAI said it has not given any clean chit to Nestle's banned Maggi noodles as it rubbished all-clear reports from two of its own empanelle...

AstraZeneca said on Tuesday that Pfizer's proposal risked disrupting its research and delaying getting life-saving new drugs to market.

Drug regulator has issued a warning letter to pharma co accusing it of obstructing its team from inspecting.

A demand was raised in RS that Govt should put in place a strong surveillance network to monitor inflow of foreign funds to NGOs.

Mukand, jointly controlled by the Bajaj and Shah families, is close to selling a part of its land at Kalwa near Thane for about Rs 600 cror...

: Reliance MediaWorks (RMW), which is locked in a takeover battle for multiplex operator Fame with rival Inox, has challenged the sale of m...

Drug maker Bafna Pharmaceuticals today made a disappointing debut on the Bombay Stock Exchange and settled below its issue price at Rs 38.5...

Pharma company Nicholas Piramal to decide on partner for its new entity to be demerged from itd R&D segment.